Home Cart 0 Sign in  
X

[ CAS No. 2752-17-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2752-17-2
Chemical Structure| 2752-17-2
Chemical Structure| 2752-17-2
Structure of 2752-17-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2752-17-2 ]

Related Doc. of [ 2752-17-2 ]

Alternatived Products of [ 2752-17-2 ]

Product Details of [ 2752-17-2 ]

CAS No. :2752-17-2 MDL No. :MFCD00466591
Formula : C4H12N2O Boiling Point : -
Linear Structure Formula :- InChI Key :GXVUZYLYWKWJIM-UHFFFAOYSA-N
M.W : 104.15 Pubchem ID :75982
Synonyms :
Amino-PEG1-amine
Chemical Name :2,2'-Oxydiethanamine

Calculated chemistry of [ 2752-17-2 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 27.84
TPSA : 61.27 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.21 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.21
Log Po/w (XLOGP3) : -1.8
Log Po/w (WLOGP) : -1.08
Log Po/w (MLOGP) : -1.06
Log Po/w (SILICOS-IT) : -0.81
Consensus Log Po/w : -0.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.91
Solubility : 851.0 mg/ml ; 8.17 mol/l
Class : Highly soluble
Log S (Ali) : 1.03
Solubility : 1120.0 mg/ml ; 10.7 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.45
Solubility : 37.0 mg/ml ; 0.355 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.22

Safety of [ 2752-17-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P305+P351+P338-P310 UN#:2735
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2752-17-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2752-17-2 ]
  • Downstream synthetic route of [ 2752-17-2 ]

[ 2752-17-2 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 111-46-6 ]
  • [ 110-91-8 ]
  • [ 2752-17-2 ]
  • [ 929-06-6 ]
Reference: [1] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 14
[2] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 14
[3] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[4] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[5] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[6] Patent: US2012/232294, 2012, A1, . Location in patent: Page/Page column 13-14; 17
[7] Patent: US2012/232292, 2012, A1, . Location in patent: Page/Page column 10; 12
[8] Patent: CN103502199, 2016, B, . Location in patent: Paragraph 0265; 0267
[9] Patent: JP5808437, 2015, B2, . Location in patent: Paragraph 0099; 0108; 0109
[10] Patent: JP2016/27052, 2016, A, . Location in patent: Paragraph 0088; 0099
[11] Patent: CN103502212, 2016, B, . Location in patent: Paragraph 0207-0208; 0213
  • 2
  • [ 111-46-6 ]
  • [ 2752-17-2 ]
  • [ 929-06-6 ]
Reference: [1] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[2] Patent: CN103502199, 2016, B, . Location in patent: Paragraph 0265; 0268
  • 3
  • [ 24345-74-2 ]
  • [ 2752-17-2 ]
Reference: [1] Chemical Communications, 2017, vol. 53, # 62, p. 8751 - 8754
[2] European Journal of Organic Chemistry, 2015, vol. 2015, # 29, p. 6458 - 6465
[3] New Journal of Chemistry, 2018, vol. 42, # 12, p. 9369 - 9372
[4] Tetrahedron, 1992, vol. 48, # 8, p. 1497 - 1506
[5] Journal of Organic Chemistry, 1985, vol. 50, # 19, p. 3453 - 3457
[6] Patent: WO2008/8797, 2008, A2, . Location in patent: Page/Page column 63
[7] Patent: WO2011/25790, 2011, A1, . Location in patent: Page/Page column 50
[8] Patent: WO2011/37610, 2011, A1, . Location in patent: Page/Page column 57
  • 4
  • [ 43113-25-3 ]
  • [ 2752-17-2 ]
YieldReaction ConditionsOperation in experiment
93% With hydrazine hydrate In chloroform for 4 h; Reflux A mixture of 15 (575 mg, 0.83 mmol) and 80percent hydrazine hydrate (8.3 mmol) was stirred under reflux for 4 h in CHCl3 (10 mL). The reaction mixture was treated with water and extracted with CHCl3, and then dried (MgSO4). After evaporation of the solvent, distillation gave the product 9a in a 93percent yield; bp 75-79 °C/5 mmHg (lit.31 bp 55-60 °C/2 mmHg); 1H NMR (500 MHz, DMSO-d6): δ 8.31 (4H, br s), 3.32 (4H, t, J=5.5 Hz), 2.63 (4H, t, J=5.5 Hz); 13C NMR (500 MHz, DMSO-d6): δ 72.7, 41.3; MS (FAB) m/z: 105 [M+H].
Reference: [1] Tetrahedron, 2016, vol. 72, # 29, p. 4258 - 4272
[2] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1982, vol. 18, # 2, p. 193 - 196[3] Khimiya Geterotsiklicheskikh Soedinenii, 1982, # 2, p. 246 - 249
[4] Journal of Organic Chemistry USSR (English Translation), 1980, vol. 16, p. 1124 - 1129[5] Zhurnal Organicheskoi Khimii, 1980, vol. 16, # 6, p. 1301 - 1307
[6] Journal of the Chemical Society, Dalton Transactions: Inorganic Chemistry (1972-1999), 1983, p. 2525 - 2528
[7] European Journal of Medicinal Chemistry, 2009, vol. 44, # 9, p. 3665 - 3671
[8] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2013, vol. 68, # 3, p. 257 - 266
[9] Journal of Coordination Chemistry, 2014, vol. 67, # 18, p. 3054 - 3066
[10] Journal of the Chinese Chemical Society, 2015, vol. 62, # 11, p. 1028 - 1034
[11] Journal of Coordination Chemistry, 2017, vol. 70, # 12, p. 2015 - 2028
[12] European Journal of Medicinal Chemistry, 2013, vol. 63, p. 907 - 923
[13] Journal of Chemical Research, 2014, vol. 38, # 4, p. 211 - 217
[14] Research on Chemical Intermediates, 2015, vol. 41, # 6, p. 3375 - 3388
[15] Journal of Coordination Chemistry, 2013, vol. 66, # 15, p. 2634 - 2646
[16] Zeitschrift fur Anorganische und Allgemeine Chemie, 2017, vol. 643, # 5, p. 379 - 386
  • 5
  • [ 929-06-6 ]
  • [ 110-91-8 ]
  • [ 2752-17-2 ]
  • [ 294-92-8 ]
Reference: [1] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 17
[2] Patent: JP5808437, 2015, B2, . Location in patent: Paragraph 0099; 0114
  • 6
  • [ 111-46-6 ]
  • [ 110-91-8 ]
  • [ 2752-17-2 ]
Reference: [1] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 14
[2] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 17
[3] Patent: US2012/232294, 2012, A1, . Location in patent: Page/Page column 13-14; 17
[4] Patent: JP5808437, 2015, B2, . Location in patent: Paragraph 0099; 0108; 0109
[5] Patent: JP2016/27052, 2016, A, . Location in patent: Paragraph 0088; 0100
  • 7
  • [ 111-46-6 ]
  • [ 110-91-8 ]
  • [ 2752-17-2 ]
  • [ 929-06-6 ]
Reference: [1] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 14
[2] Patent: US2012/232293, 2012, A1, . Location in patent: Page/Page column 12; 14
[3] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[4] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[5] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[6] Patent: US2012/232294, 2012, A1, . Location in patent: Page/Page column 13-14; 17
[7] Patent: US2012/232292, 2012, A1, . Location in patent: Page/Page column 10; 12
[8] Patent: CN103502199, 2016, B, . Location in patent: Paragraph 0265; 0267
[9] Patent: JP5808437, 2015, B2, . Location in patent: Paragraph 0099; 0108; 0109
[10] Patent: JP2016/27052, 2016, A, . Location in patent: Paragraph 0088; 0099
[11] Patent: CN103502212, 2016, B, . Location in patent: Paragraph 0207-0208; 0213
  • 8
  • [ 60792-79-2 ]
  • [ 2752-17-2 ]
Reference: [1] Journal of the American Chemical Society, 1986, vol. 108, # 11, p. 2989 - 2998
[2] Patent: US2005/43532, 2005, A1, . Location in patent: Page/Page column 5
  • 9
  • [ 111-46-6 ]
  • [ 2752-17-2 ]
  • [ 929-06-6 ]
Reference: [1] Patent: US2012/232309, 2012, A1, . Location in patent: Page/Page column 14-15; 17
[2] Patent: CN103502199, 2016, B, . Location in patent: Paragraph 0265; 0268
  • 10
  • [ 1074-82-4 ]
  • [ 111-44-4 ]
  • [ 2752-17-2 ]
YieldReaction ConditionsOperation in experiment
30% With potassium hydroxide In water EXAMPLE 38
Preparation of 1,5-diamino-3-oxapentane
1,5-Dichloro-3-oxapentane is treated with potassium phthalimid, followed by hydrazinolysis of the resulting diphthalimido-derivative and consecutive acidification whereby the bis-hydrochloride of the title compound is obtained.
The bis-hydrochloride is treated with a very concentrated (approx. 10N) solution of potassium hydroxide in water and continuously extracted with benzene in a liquid-liquid extractor for several (three to five) days.
The solvent is evaporated and the liquid residue is distilled under reduced pressure giving the desire compound.
b.p.: 48° - 50° /1mm Hg
Yield 30percent (from the initial 1,5-dichloro-3-oxapentane).
PMR (CDCl3): --NH2: 1.30 ppm (singlet: 4H); --CH2 --N: 2.90 ppm (triplet: 4H); --CH2 --O: 3.50 ppm (triplet: 4H).
30% With potassium hydroxide In water EXAMPLE 38
Preparation of 1,5-diamino-3-oxapentane
1,5-Dichloro-3-oxapentane is treated with potassium phthalimid, followed by hydrazinolysis of the resulting diphthalimido-derivative and consecutive acidification whereby the bis-hydrochloride of the title compound is obtained.
The bis-hydrochloride is treated with a very concentrated (approx. 10N) solution of potassium hydroxide in water and continuously extracted with benzene in a liquid-liquid extractor for several (three to five) days.
The solvent is evaporated and the liquid residue is distilled under reduced pressure giving the desire compound.
b.p.: 48° - 50°11mm Hg:
Yield 30percent (from the initial 1,5-dichloro-3-oxapentane); PMR (CDCl3): --NH2: 1.30 ppm (singlet: 4H); --CH2 --N: 2.90 ppm (triplet: 4H); --CH2 --O: 3.50 ppm (triplet: 4H).
Reference: [1] Patent: US4156683, 1979, A,
[2] Patent: US3966766, 1976, A,
  • 11
  • [ 141-43-5 ]
  • [ 2752-17-2 ]
Reference: [1] Patent: US4083873, 1978, A,
  • 12
  • [ 81539-80-2 ]
  • [ 2752-17-2 ]
  • [ 61020-43-7 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1982, vol. 18, # 2, p. 193 - 196[2] Khimiya Geterotsiklicheskikh Soedinenii, 1982, # 2, p. 246 - 249
  • 13
  • [ 136918-14-4 ]
  • [ 2752-17-2 ]
Reference: [1] Zeitschrift fuer Anorganische und Allgemeine Chemie, 2014, vol. 640, # 10, p. 2062 - 2071,10
  • 14
  • [ 111-44-4 ]
  • [ 2752-17-2 ]
Reference: [1] Chemistry - A European Journal, 2012, vol. 18, # 25, p. 7680 - 7685
  • 15
  • [ 141-43-5 ]
  • [ 110-85-0 ]
  • [ 2752-17-2 ]
Reference: [1] Yakugaku Zasshi, 1955, vol. 75, p. 1318,1319,1321[2] Chem.Abstr., 1956, p. 10106
  • 16
  • [ 7647-01-0 ]
  • [ 43113-25-3 ]
  • [ 64-19-7 ]
  • [ 2752-17-2 ]
  • [ 88-99-3 ]
Reference: [1] Chemische Berichte, 1905, vol. 38, p. 3413
  • 17
  • [ 2752-17-2 ]
  • [ 60792-79-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2009, vol. 44, # 9, p. 3665 - 3671
  • 18
  • [ 2752-17-2 ]
  • [ 24424-99-5 ]
  • [ 127828-22-2 ]
YieldReaction ConditionsOperation in experiment
71.5% at 0 - 20℃; This compound was synthesized according to the procedure described previously with slight modifications.25 To a cooled (0 °C) solution of 2,2'-oxybis(ethylamine) (10.0 mL, 94.1 mmol) in methanol (1000 mL) was added dropwise a solution of di-tert-butyl dicarbonate ((Boc)2O; 10.3 g, 47.0 mmol) in THF (300 mL), and the mixture was stirred for 1 h at the same temperature and additional 24 h at room temperature. After removing the solvent in vacuo, the residue was dissolved in 1 N NaOH (200 mL), and extracted with chloroform (300 mL .x. 3). The organic phases were combined, dried over anhydrous MgSO4. The solvent was removed in vacuo to provide 1 as a colorless oil (6.88 g, 71.5percent). 1H NMR (CDCl3): δ 1.39 (9H, s, Boc), 2.79-2.82 (2H, t, CH2), 3.24-3.28 (2H, dd, CH2), 3.41-3.43 (2H, t, CH2), 3.44-3.47 (2H, t, CH2), 5.00 (1H, d, NH). ESI-MS (M+H)+: m/z 205, found: 205
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 17, p. 2915 - 2919
[2] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 2, p. 978 - 984
[3] Journal of the American Chemical Society, 2010, vol. 132, # 21, p. 7291 - 7293
[4] Chemical Communications, 2017, vol. 53, # 62, p. 8751 - 8754
[5] Chemistry - An Asian Journal, 2012, vol. 7, # 2, p. 272 - 276
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2752-17-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 74654-07-2

[ 74654-07-2 ]

2-(2-(2-Methoxyethoxy)ethoxy)ethanamine

Similarity: 0.93

Chemical Structure| 68960-97-4

[ 68960-97-4 ]

3,6,9,12-Tetraoxatetradecane-1,14-diamine

Similarity: 0.93

Chemical Structure| 86770-74-3

[ 86770-74-3 ]

2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 6338-55-2

[ 6338-55-2 ]

2-(2-(2-Aminoethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 31576-51-9

[ 31576-51-9 ]

2-(2-Methoxyethoxy)ethanamine

Similarity: 0.93

Ethers

Chemical Structure| 74654-07-2

[ 74654-07-2 ]

2-(2-(2-Methoxyethoxy)ethoxy)ethanamine

Similarity: 0.93

Chemical Structure| 68960-97-4

[ 68960-97-4 ]

3,6,9,12-Tetraoxatetradecane-1,14-diamine

Similarity: 0.93

Chemical Structure| 86770-74-3

[ 86770-74-3 ]

2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 6338-55-2

[ 6338-55-2 ]

2-(2-(2-Aminoethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 31576-51-9

[ 31576-51-9 ]

2-(2-Methoxyethoxy)ethanamine

Similarity: 0.93

Amines

Chemical Structure| 74654-07-2

[ 74654-07-2 ]

2-(2-(2-Methoxyethoxy)ethoxy)ethanamine

Similarity: 0.93

Chemical Structure| 68960-97-4

[ 68960-97-4 ]

3,6,9,12-Tetraoxatetradecane-1,14-diamine

Similarity: 0.93

Chemical Structure| 86770-74-3

[ 86770-74-3 ]

2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 6338-55-2

[ 6338-55-2 ]

2-(2-(2-Aminoethoxy)ethoxy)ethanol

Similarity: 0.93

Chemical Structure| 31576-51-9

[ 31576-51-9 ]

2-(2-Methoxyethoxy)ethanamine

Similarity: 0.93